Moderna, Inc.
MRNA
$49.04
-$0.99-1.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 352.00M | 646.00M | 973.00M | 114.00M | 86.00M |
| Total Other Revenue | 37.00M | 32.00M | 43.00M | 28.00M | 22.00M |
| Total Revenue | 389.00M | 678.00M | 1.02B | 142.00M | 108.00M |
| Cost of Revenue | 726.00M | 1.23B | 1.01B | 819.00M | 946.00M |
| Gross Profit | -337.00M | -549.00M | 8.00M | -677.00M | -838.00M |
| SG&A Expenses | 173.00M | 308.00M | 268.00M | 230.00M | 212.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 899.00M | 1.54B | 1.28B | 1.05B | 1.16B |
| Operating Income | -510.00M | -857.00M | -260.00M | -907.00M | -1.05B |
| Income Before Tax | -1.33B | -799.00M | -187.00M | -818.00M | -964.00M |
| Income Tax Expenses | 9.00M | 27.00M | 13.00M | 7.00M | 7.00M |
| Earnings from Continuing Operations | -1.34B | -826.00M | -200.00M | -825.00M | -971.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.34B | -826.00M | -200.00M | -825.00M | -971.00M |
| EBIT | -510.00M | -857.00M | -260.00M | -907.00M | -1.05B |
| EBITDA | -451.00M | -790.00M | -208.00M | -850.00M | -1.01B |
| EPS Basic | -3.40 | -2.11 | -0.51 | -2.13 | -2.52 |
| Normalized Basic EPS | -0.72 | -1.27 | -0.31 | -1.32 | -1.55 |
| EPS Diluted | -3.40 | -2.11 | -0.51 | -2.13 | -2.52 |
| Normalized Diluted EPS | -0.72 | -1.27 | -0.31 | -1.32 | -1.55 |
| Average Basic Shares Outstanding | 395.00M | 392.00M | 390.00M | 388.00M | 386.00M |
| Average Diluted Shares Outstanding | 395.00M | 392.00M | 390.00M | 388.00M | 386.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |